SeraCare Life Sciences has reorganized into three commercial business units: IVD Research, IVD Processing, and Clinical Laboratory. The company’s senior management team added five new executives to lead the units, as well as operations, R&D, and quality organizations.
 
Russell Garlick, Ph.D. will serve as chief scientific officer, focusing on expansion of the company’s R&D organization and product development pipeline. Prior to joining the company, he was co-founder of Life Sciences Group and served as chief executive officer and chief technology officer of Protein Forest, Inc. Dr. Garlick also held executive R&D positions at PerkinElmer Life Sciences and DuPont NEN Life Sciences.
 
Cheri Walker, Ph.D. will serve as chief commercial officer and will act as the head of the IVD Research and Clinical Laboratory business units in addition to overseeing corporate development activities. Previously, Dr. Walker consulted with private equity firms and both diagnostic and life science tools companies on marketing, strategy and corporate development activities. She has held senior level corporate development, marketing and business unit leadership roles at Charles River Laboratories, QIAGEN, and Invitrogen.
 
Ann McCormick will serve as chief operating officer. Ms. McCormick has extensive life science industry experience in manufacturing, laboratory and executive roles. Most recently, she co-founded and managed SeraMetrix Corp., where she was involved with developing and manufacturing protein biomarkers for oncology and autoimmune applications. Prior to that, she worked with Invitrogen for 12 years, where she held numerous manufacturing and operational leadership positions.
 
Joe Kozma will serve as vice president of IVD Process Solutions. Previously, Mr. Kozma held executive positions at Serologicals and Millipore, and was co-founder of Intergen, a manufacturer of biological and recombinant reagents for research and manufacturing of biopharmaceutical and diagnostic products.
 
Lisa Alexander will serve as vice president, Quality and Regulatory, focused on driving SeraCare’s goal to meet or surpass customers’ quality expectations, regulatory requirements and industry standards. She has significant experience leading quality and regulatory teams in the life sciences and diagnostic industries including her most recent role as vice president, Quality and Regulatory Affairs at Xcellerex (GE Healthcare).
 
“Our industry is entering a period of great change as new diagnostics technologies enable an unprecedented level of personalized medicine,” said Charles Mamrak, chief executive officer of SeraCare. “Our customers need our help in turning these changes into business opportunities. Allowing our customer-facing personnel to focus on a single, key market will make it easier for them to anticipate and meet these customers’ needs.”